Dialysis modality and mortality in polycystic kidney disease-Reference-Cited by-同舟云学术

Dialysis modality and mortality in polycystic kidney disease

Published:2018-05-18 Issue:4 Volume:22 Page:515-523
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Zhou Chenchen¹,Gu Yaodong¹,Mei Changlin²,Dai Bing²,Wang Yi¹,Xue Cheng²

Affiliation:

1. Department of Nephrology; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine; Shanghai China

2. Division of Nephrology; Changzheng hospital, Second Military Medical University; Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hdi.12673/fullpdf

Reference20 articles.

1. Autosomal dominant polycystic kidney disease: The changing face of clinical management;Ong;Lancet.,2015

2. The clinical manifestation and management of autosomal dominant polycystic kidney disease in China;Xue;Kidney Dis.,2016

3. Peritoneal dialysis for patients with autosomal dominant polycystic kidney disease;Khan;Perit Dial Int.,2017

4. Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease;Li;Am J Kidney Dis.,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peritoneal Dialysis Care for People with Diabetes, Polycystic Kidney Disease, or Advanced Liver Disease;Clinical Journal of the American Society of Nephrology;2024-01-08

2. Dialysis and Transplant Considerations in Autosomal Dominant Polycystic Kidney Disease;Advances in Kidney Disease and Health;2023-09

3. Interleukin‐6 levels can be used to estimate cardiovascular and all‐cause mortality risk in dialysis patients: A meta‐analysis and a systematic review;Immunity, Inflammation and Disease;2023-04

4. Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis;Clinical Kidney Journal;2020-11-21

5. Nocturnal Hemodialysis Compared with Conventional Dialysis for End-Stage Renal Disease Treatment in Polycystic Kidney Disease Patients;Blood Purification;2019-11-13